Standard Versus Low-Dose Weight-Adjusted Heparin in Patients Treated With the Platelet Glycoprotein IIb/IIIa Receptor Antibody Fragment Abciximab (c7E3 Fab) During Percutaneous Coronary Revascularization

✍ Scribed by A.Michael Lincoff; MD; James E. Tcheng; MD; Robert M. Califf; MD; Theodore Bass; MD; Jeffrey J. Popma; MD; Paul S. Teirstein; MD; Neal S. Kleiman; MD; Larry J. Hattel; MD; H.Vernon Anderson; MD; James J. Ferguson; MD; Catherine F. Cabot; MD; Keaven M. Anderson; PhD; Lisa G. Berdan; PA-C; Maura H. Musco; MS; Harlan F. Weisman; MD; Eric J. Topol; MD

• Book ID: 113977965
• Publisher: Elsevier Science
• Year: 1997
• Tongue: English
• Weight: 267 KB
• Volume: 79
• Category: Article
• ISSN: 0002-9149
• DOI: 10.1016/s0002-9149(96)00749-7